<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29576" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Strongyloidiasis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mora Carpio</surname>
            <given-names>Andres L.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Meseeha</surname>
            <given-names>Marcelle</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Andres Mora Carpio declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marcelle Meseeha declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>4</day>
          <month>9</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29576.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Despite its ability to cause life-threatening diseases, strongyloidiasis is one of the most neglected tropical diseases. Moreover, Strongyloides infection can last the host's lifetime due to its ability to cause autoinfection of the host. The helminth S. stercoralis mainly infects humans but also occurs naturally in domestic dogs, cats, and primates. Manifestations of infection can range from asymptomatic to life-threatening complications and require a high degree of suspicion to make the diagnosis. This activity examines the pathogenesis, disease manifestations, and management of strongyloidiasis and highlights the role of the interprofessional team in caring for patients affected by this disease.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the life cycle and mechanism of infection of Strongyloides stercoralis.</p></list-item><list-item><p>Describe the clinical presentation of a patient infected with Strongyloides stercoralis.</p></list-item><list-item><p>Summarize the medical management of a patient infected with Strongyloides stercoralis.</p></list-item><list-item><p>Outline the importance of the interprofessional team in advancing care for patients infected by Strongyloides stercoralis.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29576&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29576">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29576.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p><italic toggle="yes">Strongyloides stercoralis</italic>, commonly known as threadworm, is a soil-transmitted human parasite belonging to a group of nematodes called roundworms. Although prevalent almost worldwide, except only in the far north and south, the global burden of this parasitic infection is still underestimated because of the unavailability of precise data from endemic areas.<xref ref-type="bibr" rid="article-29576.r1">[1]</xref>
<italic toggle="yes">S. stercoralis, </italic>therefore,&#x000a0;becomes one of the most overlooked parasitic infections among the "neglected tropical diseases" (NTDs).<xref ref-type="bibr" rid="article-29576.r2">[2]</xref></p>
        <p>The helminth, <italic toggle="yes">S. stercoralis,</italic> mainly infects humans but also occurs naturally in domestic dogs, cats, and primates.<xref ref-type="bibr" rid="article-29576.r3">[3]</xref>&#x000a0;The feature that makes it unique among other human nematodes is the ability to give rise to a progeny of free-living worms from rhabditiform larvae shed in human feces, which reproduce to form infective, skin-penetrating filariform larvae in the external environment.<xref ref-type="bibr" rid="article-29576.r3">[3]</xref>&#x000a0;Humans infected with <italic toggle="yes">S. stercoralis</italic> present with varying degrees of clinical manifestations ranging from asymptomatic carriers to acute strongyloidiasis and disseminated infections.<xref ref-type="bibr" rid="article-29576.r3">[3]</xref></p>
        <p>Strongyloidiasis is the term used to indicate infection by <italic toggle="yes">Strongyloides stercoralis</italic>. It differs from other helminth infections by its ability to cause overwhelming hyperinfection in immunocompromised individuals.<xref ref-type="bibr" rid="article-29576.r4">[4]</xref>&#x000a0;Strongyloides infection can last the host's lifetime due to its autoinfection life cycle and cause a wide spectrum of diseases ranging from asymptomatic eosinophilia to severe, life-threatening disseminated disease in immunocompromised patients.<xref ref-type="bibr" rid="article-29576.r5">[5]</xref></p>
      </sec>
      <sec id="article-29576.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p><italic toggle="yes">Strongyloides stercoralis</italic> is a soil-transmitted helminth. It is classified as a roundworm or nematode. There are more than 50 species of <italic toggle="yes">Strongyloides</italic>. Most of them do not infect humans.&#x000a0;Strongyloidiasis, the disease caused by <italic toggle="yes">S. stercoralis</italic> in humans, is contracted mainly through the transcutaneous route.<xref ref-type="bibr" rid="article-29576.r3">[3]</xref>&#x000a0;Other modes of transmission include the fecal-oral and anal-oral routes. It can also be transmitted through organ transplantation from an infected donor.<xref ref-type="bibr" rid="article-29576.r6">[6]</xref></p>
        <p>Host factors such as&#x000a0;HIV infection, human T-lymphotropic virus type 1 (HTLV-1) infection, and alcoholism have been reported as risk factors for Strongyloidiasis. The most&#x000a0;prominent risk factors for severe disease include immunosuppressive therapies (including corticosteroid use), diseases like diabetes, HIV, HTLV infection, and alcoholism.<xref ref-type="bibr" rid="article-29576.r7">[7]</xref> Poor sanitation of households and walking barefoot have been postulated to play an important role in the etiology of this infection as well.<xref ref-type="bibr" rid="article-29576.r7">[7]</xref>&#x000a0;Contrary to popular belief, HIV does not seem to be a risk factor for superinfection. This is likely secondary to HIV-induced CD4 cell immunosuppression predisposing more to bacterial and viral infections than parasitic infections.<xref ref-type="bibr" rid="article-29576.r8">[8]</xref></p>
      </sec>
      <sec id="article-29576.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p><italic toggle="yes">Strongyloides stercoralis</italic> is prevalent in almost every part of the world except Antarctica. According to one study, this soil-transmitted nematode is estimated to have infected 370 million people globally, especially in the tropical and subtropical regions, where 10 to 40% of the population is affected.<xref ref-type="bibr" rid="article-29576.r7">[7]</xref>&#x000a0;A 2021 systemic review revealed the highest prevalence of this infection in the Western Pacific region (affecting 9 to 21% of the population).<xref ref-type="bibr" rid="article-29576.r9">[9]</xref>&#x000a0;The&#x000a0;Eastern Mediterranean Region was noted to have the highest seroprevalence, with as high as 40% of the population being affected.<xref ref-type="bibr" rid="article-29576.r9">[9]</xref></p>
        <p>Worldwide and local prevalence of <italic toggle="yes">Strongyloides</italic> is seriously underestimated because of the low sensitivity of tests and poor reporting in high-incidence countries. It is more frequently found in warm, moist areas and&#x000a0;areas with poor sanitary conditions. Some studies have reported incidences as high as 91% in Gabon and 75% in Peru, but the prevalence varies widely depending on the diagnostic methods used.<xref ref-type="bibr" rid="article-29576.r1">[1]</xref> Studies identifying the incidence of this disease are non-existent.<xref ref-type="bibr" rid="article-29576.r1">[1]</xref></p>
        <p>In developed countries, Strongyloidiasis is more frequently seen in farmers and miners, as well as immigrant populations, tourists, and military personnel returning from high-prevalence areas. In the United States, the highest incidence is in immigrants from Africa and Asia (46% in one&#x000a0;study evaluating Sudanese refugees), followed by Central and Latin America.<xref ref-type="bibr" rid="article-29576.r10">[10]</xref>&#x000a0;It is important to note that refugee populations receive deworming therapy when entering the United States.</p>
        <p>There is a slight predilection for the male sex. This is thought to be due to increased exposure to the source of infection due to involvement in farming, fieldwork, etc.<xref ref-type="bibr" rid="article-29576.r11">[11]</xref></p>
      </sec>
      <sec id="article-29576.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>
<bold>Life Cycle of&#x000a0;<italic toggle="yes">Strongyloides stercoralis</italic></bold>
</p>
        <p>The distinctive nature of the life cycle of this human parasite is attributed to its ability to cause autoinfection. Its life cycle comprises a free-living phase and a parasitic phase.<xref ref-type="bibr" rid="article-29576.r12">[12]</xref>&#x000a0;The free-living&#x000a0;phase begins when rhabditiform larvae passed in stools grow into infective skin-penetrating filariform larvae or develop into adult worms which reproduce sexually to give rise to the second generation of filariform larvae.<xref ref-type="bibr" rid="article-29576.r12">[12]</xref>&#x000a0;The parasitic phase of the life cycle&#x000a0;begins with&#x000a0;skin penetration by the filariform larvae. These larvae then migrate via the bloodstream or lymphatics to reside in the gut. Within the small intestine, these larvae mature into adult females, which reproduce by parthenogenesis and give rise to rhabditiform larvae which are either excreted in feces or develop into filariform larvae to cause autoinfection.<xref ref-type="bibr" rid="article-29576.r13">[13]</xref></p>
        <p>
<bold>Parasitic Phase</bold>
</p>
        <p>Infection occurs through skin contact with soil containing filariform (infective) larvae. After penetrating the skin, larvae travel to the lungs, where they mature. It then travels up the trachea and is eventually swallowed. In the alimentary canal, the larvae invade the mucosa of the proximal small intestine. Here they mature and lay eggs.<xref ref-type="bibr" rid="article-29576.r13">[13]</xref>&#x000a0;The adult form can live in the intestinal mucosa for up to 5 years. The eggs hatch inside the intestinal mucosa and release rhabditiform (non-infective) larvae that travel to the intestinal lumen. They are eventually excreted in&#x000a0;the feces. The larvae excreted in the soil may mature into an ineffective filariform larva or complete a free-living cycle where the male and female produce rhabditiform larvae that can later mature into filariform larvae.<xref ref-type="bibr" rid="article-29576.r1">[1]</xref></p>
        <p>
<bold>Autoinfection</bold>
</p>
        <p>Some rhabditiform larvae mature inside the intestinal lumen into filariform larvae. These newly hatched larvae can then penetrate the intestinal mucosa or the perianal skin and complete an autoinfection cycle. This allows the organism to perpetuate the infection inside the host.<xref ref-type="bibr" rid="article-29576.r13">[13]</xref>&#x000a0;Autoinfection is generally limited by an intact immune response. However, even in an immunocompetent host, a low level of autoinfection can occur and, subsequently, cause chronic infections for decades and may only lead to clinical manifestations when superimposed immunosuppression exists.<xref ref-type="bibr" rid="article-29576.r14">[14]</xref></p>
        <p>
<bold>Hyperinfection</bold>
</p>
        <p>Hyperinfection syndrome is the most severe manifestation of the disease, with high mortality rates. This occurs in chronically infected individuals that become immunosuppressed or in acutely infected immunosuppressed patients.<xref ref-type="bibr" rid="article-29576.r1">[1]</xref>&#x000a0;It stems from uncontrolled and accelerated autoinfection resulting in the dissemination of the larvae to end organs like the liver or brain. Sepsis is a common complication caused by bacterial translocation from the intestinal wall in patients suffering from hyperinfection syndrome.</p>
      </sec>
      <sec id="article-29576.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>In most cases, Strongyloidiasis is asymptomatic, especially in immunocompetent individuals.<xref ref-type="bibr" rid="article-29576.r1">[1]</xref>&#x000a0;Often, the only sign of infection&#x000a0;is unexplained peripheral eosinophilia. Some studies report nonspecific symptoms in more than 50% of the affected patients.<xref ref-type="bibr" rid="article-29576.r15">[15]</xref></p>
        <p>
<bold>Acute Infection</bold>
</p>
        <p>Acute infection may show an itchy serpiginous skin rash in the area where the larvae penetrate the skin. When filariform larvae in fecal-contaminated soil enter the body through skin penetration, intense pruritus, congestion, and edema is noted at the portal of entry.<xref ref-type="bibr" rid="article-29576.r3">[3]</xref>&#x000a0;This is known as ground itch and is usually present in feet or hands but can be perianal, abdominal, or virtually anywhere in the body. This intense urticaria can last for up to 3 weeks.<xref ref-type="bibr" rid="article-29576.r16">[16]</xref>&#x000a0;Intradermal migration is very fast (5 cm to 15 cm an hour), and the rash it causes is known as larva currens.<xref ref-type="bibr" rid="article-29576.r3">[3]</xref>&#x000a0;</p>
        <p>Larva currens or &#x0201c;running&#x0201d; larva is a pathognomonic dermatologic manifestation of strongyloidiasis and can be seen with autoinfection as well.&#x000a0;Larva currens manifest as a raised, pink, pruritic, serpiginous streak and can progress approximately 5 to 15 cm per hour.<xref ref-type="bibr" rid="article-29576.r17">[17]</xref></p>
        <p>Passage of the larvae through the lungs can give a dry cough and cause a Loeffler-like syndrome with dyspnea, wheezing, eosinophilia, and migratory pulmonary infiltrates. The larvae travel through venules and lymphatics to enter pulmonary circulation producing pulmonary hemorrhages and cough. Eosinophilic infiltration of the alveolar spaces often results in pneumonitis as well.<xref ref-type="bibr" rid="article-29576.r18">[18]</xref>&#x000a0;</p>
        <p>Intestinal symptoms&#x000a0;include diarrhea, vomiting, and epigastric pain.</p>
        <p>Hyperinfection syndrome presents with fever, gram-negative bacteremia, and sepsis with signs of end-organ damage (hemoptysis, gastrointestinal bleeding, ileus, hyponatremia).</p>
        <p>
<bold>Chronic Infection</bold>
</p>
        <p><italic toggle="yes">Strongyloides stercoralis</italic> can also cause chronic infections, which can persist for years in humans. Chronic&#x000a0;<italic toggle="yes">Strongyloides stercoralis </italic>infections present with&#x000a0;cough, rhonchi, dyspnea, abdominal pain, anorexia, diarrhea, and/or constipation.<xref ref-type="bibr" rid="article-29576.r19">[19]</xref>&#x000a0;Respiratory and gastrointestinal symptoms tend to be mild in chronic forms, and dermatologic manifestations such as urticaria and larva currents can still be seen.<xref ref-type="bibr" rid="article-29576.r20">[20]</xref>&#x000a0;</p>
        <p>
<bold>Hyperinfection</bold>
</p>
        <p>Hyperinfection is caused by accelerated autoinfection of the parasite within the host leading to a high parasite burden and severe disease. The signs and symptoms of hyperinfection are similar to symptoms of increased larval migration within the organs.&#x000a0;Disseminated disease occurs with hyperinfection syndrome leading to the spread of larvae to distant organs such as the liver, pancreas, kidneys, mesenteric lymph nodes, brain, and skeletal muscles.<xref ref-type="bibr" rid="article-29576.r21">[21]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-29576.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Definitive diagnosis of <italic toggle="yes">Strongyloides stercoralis</italic>&#x000a0;requires the detection of larvae in the stool specimen; however, this method is limited due to scanty and intermittent excretion of larvae in most cases of strongyloidiasis.&#x000a0;Intestinal biopsy, when performed, can sometimes demonstrate parasites in the gastric crypts or duodenal glands, as well as eosinophilic infiltration of the lamina propria.<xref ref-type="bibr" rid="article-29576.r21">[21]</xref>&#x000a0;However, it must be noted that routine endoscopy has no role in evaluating a patient suspected to have strongyloidiasis. Cell-free&#x000a0;DNA of the parasite can also be detected in urine specimens of infected individuals.<xref ref-type="bibr" rid="article-29576.r22">[22]</xref>&#x000a0;On sputum culture, Gram staining and&#x000a0;routine acid-fast staining can reveal strongyloidiasis.<xref ref-type="bibr" rid="article-29576.r23">[23]</xref>&#x000a0;Serologic testing is also available for the diagnosis of this disease.&#x000a0;</p>
        <p>The sensitivity and specificity of these tests, however, are not high. The standard stool examination has a sensitivity of only 21%. Stool concentration methods, such as the Baermann technique (72% sensitive) or agar plate culture (89% sensitive), can still fail to yield a diagnosis despite consecutive samples.<xref ref-type="bibr" rid="article-29576.r24">[24]</xref>&#x000a0;Serologic tests (IFAT, ELISA, NIE-LIPS) tend to have better sensitivity.<xref ref-type="bibr" rid="article-29576.r25">[25]</xref>&#x000a0;The disadvantage of serologic techniques is the lack of specificity because of cross-reactivity with other helminthic antigens, specially filariasis.&#x000a0;The ELISA test has the benefit of being able to detect coproantigen and thus works as a marker of current infection.</p>
        <p>With the above limitations in mind, the gold standard tests for <italic toggle="yes">S. stercoralis</italic>&#x000a0;diagnosis are yet to be developed. In most cases, both stool and serologic evaluation is indicated. PCR and RT-PCR tests have been developed and show promising results with nearly 100% specificity and very high sensitivity, but they are not widely available.<xref ref-type="bibr" rid="article-29576.r26">[26]</xref></p>
        <p>Peripheral eosinophilia is a common finding in patients with chronic infections.<xref ref-type="bibr" rid="article-29576.r27">[27]</xref>&#x000a0;However, the sensitivity of eosinophilia for strongyloidiasis is low. Moreover, in patients with&#x000a0;hyperinfection syndrome, peripheral eosinophilia is usually absent.<xref ref-type="bibr" rid="article-29576.r28">[28]</xref>&#x000a0;</p>
        <p>The diagnosis of chronic strongyloidiasis is especially challenging due to low parasitic load, which results in low sensitivity of stool microscopy and low specificity of serology.</p>
        <p>As discussed above, the sensitivity of stool microscopy and serology is low, especially in patients with acute or chronic infections. It is useful to note that serologic tests have a high negative predictive value and are quite useful in excluding strongyloidiasis.<xref ref-type="bibr" rid="article-29576.r29">[29]</xref>&#x000a0;A 2019 study from the UK evaluating&#x000a0;the performance of standard diagnostic techniques for this condition in patients with microscopically proven infection reported that patients with proven infection had lower serology values than those who were diagnosed based on serology and eosinophilia alone, suggesting a correlation between immunologic control of strongyloidiasis and the amplitude of the humoral response.<xref ref-type="bibr" rid="article-29576.r29">[29]</xref></p>
        <p>Hyperinfection can be diagnosed by studying stool, body fluids, and/or tissue with adequate sensitivity because, in this state, the host generally has a high burden of readily detectable parasites.&#x000a0;</p>
      </sec>
      <sec id="article-29576.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The goal of treatment is to eradicate the parasite completely and is indicated for symptomatic and asymptomatic individuals regardless of their immune status.</p>
        <p>Uncomplicated strongyloidiasis is treated with ivermectin (200 micrograms/kg for two days), thiabendazole (25 mg/kg/day for three days), or albendazole (400 mg twice a day for 3-7 days).<xref ref-type="bibr" rid="article-29576.r30">[30]</xref><xref ref-type="bibr" rid="article-29576.r3">[3]</xref>&#x000a0;Response to treatment should be ensured with serial stool testing or anti-Strongyloides titer testing for one to two years in all patients.<xref ref-type="bibr" rid="article-29576.r31">[31]</xref></p>
        <p>Patients with evidence of hyperinfection syndrome are treated with ivermectin for at least two weeks or until stool is negative for two consecutive weeks.<xref ref-type="bibr" rid="article-29576.r3">[3]</xref>&#x000a0;Broad-spectrum antibiotics with coverage for enteric bacteria should also be added to ivermectin in these patients. Of note, for individuals from areas of Africa that are endemic to loiasis, screening for loiasis microfilaremia is indicated prior to treatment with ivermectin, as administration of this drug in such patients can lead to encephalopathy.&#x000a0;</p>
        <p>Of the agents outlined above, the preferred therapy is ivermectin.<xref ref-type="bibr" rid="article-29576.r32">[32]</xref>&#x000a0;This regimen has shown the best efficacy, and the side effect profile is similar to albendazole, as demonstrated by the latest meta-analysis.<xref ref-type="bibr" rid="article-29576.r32">[32]</xref>&#x000a0;Second-line therapy is albendazole because it has lower efficacy than ivermectin.<xref ref-type="bibr" rid="article-29576.r32">[32]</xref> For the most part, thiabendazole has fallen out of favor due to the increased incidence of adverse events, although it remains as effective as ivermectin.<xref ref-type="bibr" rid="article-29576.r32">[32]</xref></p>
        <p>Treatment may be prolonged in immunocompromised individuals. Stopping or decreasing immunosuppressive therapy should be considered, and treatment should ideally be continued until larvae are undetectable in stool, urine, and sputum for at least 14 days.</p>
      </sec>
      <sec id="article-29576.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>For pulmonary symptoms:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute respiratory distress syndrome (ARDS)</p>
          </list-item>
          <list-item>
            <p>Pneumonia</p>
          </list-item>
          <list-item>
            <p>Bronchial asthma</p>
          </list-item>
          <list-item>
            <p>Pneumonitis</p>
          </list-item>
        </list>
        <p>For gastrointestinal symptoms:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute appendicitis</p>
          </list-item>
          <list-item>
            <p>Intestinal obstruction</p>
          </list-item>
          <list-item>
            <p>Inflammatory bowel syndrome</p>
          </list-item>
          <list-item>
            <p>Proctitis</p>
          </list-item>
          <list-item>
            <p>Loffler syndrome</p>
          </list-item>
          <list-item>
            <p>Peritonitis</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29576.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>With treatment, the prognosis of acute and chronic infections is generally favorable. However, in patients with hyperinfection syndrome and disseminated infection, the mortality rate is reported to be as high as 70 to 100%.<xref ref-type="bibr" rid="article-29576.r33">[33]</xref>&#x000a0;Risk factors for increased mortality in patients affected with this disease include underlying immunosuppression (due to underlying illness and/or immunosuppressive therapy), concomitant bacteremia, and delayed diagnosis.<xref ref-type="bibr" rid="article-29576.r34">[34]</xref><xref ref-type="bibr" rid="article-29576.r21">[21]</xref></p>
        <p>A 2006 study from Hong Kong evaluated the clinical course and outcome of&#x000a0;disseminated strongyloidiasis over a 10-year period. Seven patients were identified, of which 5 had pulmonary involvement at the time of presentation and subsequently died despite anthelmintic therapy and aggressive supportive therapy. Pulmonary and bowel symptoms were prominent in this series, and peripheral eosinophilia was universally absent.<xref ref-type="bibr" rid="article-29576.r33">[33]</xref></p>
      </sec>
      <sec id="article-29576.s11" sec-type="Complications">
        <title>Complications</title>
        <p>As outlined above, the most dreaded consequence of <italic toggle="yes">Strongyloides stercoralis</italic> infection is&#x000a0;hyperinfection syndrome, which is associated with severe disseminated disease and frequently leads to multiorgan failure with eventual death despite anthelmintic therapy.<xref ref-type="bibr" rid="article-29576.r33">[33]</xref>&#x000a0;Additionally, patients with severe diseases are also at risk of gram-negative bacteremia and sepsis, which is why broad-spectrum antibiotics are recommended in addition to antihelminthic therapy in patients with severe disease.&#x000a0;</p>
      </sec>
      <sec id="article-29576.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Prevention of chronic and disseminated strongyloidiasis should be considered in patients at high risk for the disease. This includes the screening of asymptomatic patients, especially those with exposure to endemic areas. Serologic testing in asymptomatic individuals is warranted in patients:<xref ref-type="bibr" rid="article-29576.r35">[35]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Patients with exposure to endemic areas that now require immunosuppressive therapies</p>
          </list-item>
          <list-item>
            <p>Those who have relevant environmental exposure and are now becoming organ donors</p>
          </list-item>
          <list-item>
            <p>Military personnel with a history of service in endemic areas, regardless of how remote the exposure was</p>
          </list-item>
          <list-item>
            <p>Immigrants and refugees from endemic areas</p>
          </list-item>
        </list>
        <p>As with other soil-transmitted helminth infections, prevention of disease incidence in endemic areas is undertaken by sanitation, access to clean water, hand washing, and general hygiene.<xref ref-type="bibr" rid="article-29576.r36">[36]</xref></p>
      </sec>
      <sec id="article-29576.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The diagnosis and management of strongyloidiasis require a high degree of clinical suspicion and careful care coordination among interprofessional healthcare team members to ensure early diagnosis, appropriate treatment, and effective eradication of the disease.&#x000a0;The pharmacist plays a crucial role in ensuring medication compliance to ensure eradication occurs with the first treatment course. Subsequent monitoring of all patients is required to ensure that larvae are no longer detectable in the body fluids; nurses participate extensively in monitoring, answering patient questions, reporting/charting therapy progress for the clinician team, and educating patients regarding the need for effective therapy despite minimal symptoms.&#x000a0;Response to treatment should be followed up with serial stool exams or anti-<italic toggle="yes">Strongyloides</italic>&#x000a0;titers for one to two years in all patients.<xref ref-type="bibr" rid="article-29576.r31">[31]</xref>&#x000a0;This requires extensive patient counseling by clinical providers and specialty nurses to ensure patients remain compliant with the treatment plan. A well-coordinated interprofessional team of nurses, pharmacists, and clinical providers can significantly reduce the burden of this disease and ensure better clinical outcomes. [Level 5]</p>
      </sec>
      <sec id="article-29576.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29576&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29576">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/infectious-disease/strongyloidiasis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29576">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29576/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29576">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-29576.s15">
        <title>References</title>
        <ref id="article-29576.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sch&#x000e4;r</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Trostdorf</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Giardina</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Khieu</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Muth</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marti</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Vounatsou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Odermatt</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Strongyloides stercoralis: Global Distribution and Risk Factors.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2013</year>
            <volume>7</volume>
            <issue>7</issue>
            <fpage>e2288</fpage>
            <pub-id pub-id-type="pmid">23875033</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Genta</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Global prevalence of strongyloidiasis: critical review with epidemiologic insights into the prevention of disseminated disease.</article-title>
            <source>Rev Infect Dis</source>
            <year>1989</year>
            <season>Sep-Oct</season>
            <volume>11</volume>
            <issue>5</issue>
            <fpage>755</fpage>
            <page-range>755-67</page-range>
            <pub-id pub-id-type="pmid">2682948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nutman</surname>
                <given-names>TB</given-names>
              </name>
            </person-group>
            <article-title>Human infection with Strongyloides stercoralis and other related Strongyloides species.</article-title>
            <source>Parasitology</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>144</volume>
            <issue>3</issue>
            <fpage>263</fpage>
            <page-range>263-273</page-range>
            <pub-id pub-id-type="pmid">27181117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toledo</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz-Antoli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Esteban</surname>
                <given-names>JG</given-names>
              </name>
            </person-group>
            <article-title>Strongyloidiasis with emphasis on human infections and its different clinical forms.</article-title>
            <source>Adv Parasitol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>88</volume>
            <fpage>165</fpage>
            <page-range>165-241</page-range>
            <pub-id pub-id-type="pmid">25911368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Greaves</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Coggle</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pollard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Aliyu</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>EM</given-names>
              </name>
            </person-group>
            <article-title>Strongyloides stercoralis infection.</article-title>
            <source>BMJ</source>
            <year>2013</year>
            <month>Jul</month>
            <day>30</day>
            <volume>347</volume>
            <fpage>f4610</fpage>
            <pub-id pub-id-type="pmid">23900531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Czeresnia</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Strongyloides stercoralis.</article-title>
            <source>Lung</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>200</volume>
            <issue>2</issue>
            <fpage>141</fpage>
            <page-range>141-148</page-range>
            <pub-id pub-id-type="pmid">35396957</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mirzaei</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ashrafi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Atrkar Roushan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Mahmoudi</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Shenavar Masooleh</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Rahmati</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Saadat</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mirjalali</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sharifdini</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Strongyloides stercoralis and other intestinal parasites in patients receiving immunosuppressive drugs in northern Iran: a closer look at risk factors.</article-title>
            <source>Epidemiol Health</source>
            <year>2021</year>
            <volume>43</volume>
            <fpage>e2021009</fpage>
            <pub-id pub-id-type="pmid">33494130</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siegel</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>Is human immunodeficiency virus infection a risk factor for Strongyloides stercoralis hyperinfection and dissemination.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2012</year>
            <volume>6</volume>
            <issue>7</issue>
            <fpage>e1581</fpage>
            <pub-id pub-id-type="pmid">22860137</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eslahi</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Badri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nahavandi</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Houshmand</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dalvand</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Riahi</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Johkool</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Asadi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hoseini Ahangari</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Taghipour</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zibaei</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Khademvatan</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of strongyloidiasis in the general population of the world: a systematic review and meta-analysis.</article-title>
            <source>Pathog Glob Health</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>115</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-20</page-range>
            <pub-id pub-id-type="pmid">33433291</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ostera</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Blum</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Strongyloidiasis: Risk and Healthcare Access for Latin American Immigrants Living in the United States.</article-title>
            <source>Curr Trop Med Rep</source>
            <year>2016</year>
            <volume>3</volume>
            <fpage>1</fpage>
            <page-range>1-3</page-range>
            <pub-id pub-id-type="pmid">26925367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharifdini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kia</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Ashrafi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hosseini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mirhendi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mohebali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kamranrashani</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>An Analysis of Clinical Characteristics of Strongyloides stercoralis in 70 indigenous patients in Iran.</article-title>
            <source>Iran J Parasitol</source>
            <year>2014</year>
            <season>Apr-Jun</season>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>155</fpage>
            <page-range>155-62</page-range>
            <pub-id pub-id-type="pmid">25848380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Page</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Judd</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bradbury</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>The Unique Life Cycle of Strongyloides stercoralis and Implications for Public Health Action.</article-title>
            <source>Trop Med Infect Dis</source>
            <year>2018</year>
            <month>May</month>
            <day>25</day>
            <volume>3</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">30274449</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chavez</surname>
                <given-names>IN</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Assi&#x000e9;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bryant</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Samuel</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Hallem</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Skin-penetrating nematodes exhibit life-stage-specific interactions with host-associated and environmental bacteria.</article-title>
            <source>BMC Biol</source>
            <year>2021</year>
            <month>Oct</month>
            <day>07</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>221</fpage>
            <pub-id pub-id-type="pmid">34620172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Whitlock</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Dietrich</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary hyperinfection syndrome with Strongyloides stercoralis.</article-title>
            <source>Chest</source>
            <year>1990</year>
            <month>Jun</month>
            <volume>97</volume>
            <issue>6</issue>
            <fpage>1475</fpage>
            <page-range>1475-7</page-range>
            <pub-id pub-id-type="pmid">2347234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sawhney</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barros</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Strongyloides stercoralis: there but not seen.</article-title>
            <source>Curr Opin Infect Dis</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>500</fpage>
            <page-range>500-4</page-range>
            <pub-id pub-id-type="pmid">20733481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meinking</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Burkhart</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Burkhart</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Changing paradigms in parasitic infections: common dermatological helminthic infections and cutaneous myiasis.</article-title>
            <source>Clin Dermatol</source>
            <year>2003</year>
            <season>Sep-Oct</season>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>407</fpage>
            <page-range>407-16</page-range>
            <pub-id pub-id-type="pmid">14678721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>ARTHUR</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>SHELLEY</surname>
                <given-names>WB</given-names>
              </name>
            </person-group>
            <article-title>Larva currens; a distinctive variant of cutaneous larva migrans due to Strongyloides stercoralis.</article-title>
            <source>AMA Arch Derm</source>
            <year>1958</year>
            <month>Aug</month>
            <volume>78</volume>
            <issue>2</issue>
            <fpage>186</fpage>
            <page-range>186-90</page-range>
            <pub-id pub-id-type="pmid">13558704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Puthiyakunnon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boddu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Strongyloidiasis--an insight into its global prevalence and management.</article-title>
            <source>PLoS Negl Trop Dis</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>e3018</fpage>
            <pub-id pub-id-type="pmid">25121962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tamarozzi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Martello</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Giorli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fittipaldo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Staffolani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Montresor</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bisoffi</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Buonfrate</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Morbidity Associated with Chronic <italic>Strongyloides stercoralis</italic> Infection: A Systematic Review and Meta-Analysis.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>100</volume>
            <issue>6</issue>
            <fpage>1305</fpage>
            <page-range>1305-1311</page-range>
            <pub-id pub-id-type="pmid">30963990</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Grattan</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Barker</surname>
                <given-names>TH</given-names>
              </name>
            </person-group>
            <article-title>Case 4. Chronic urticaria due to strongyloidiasis.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2002</year>
            <month>Jan</month>
            <volume>27</volume>
            <issue>1</issue>
            <fpage>84</fpage>
            <page-range>84-5</page-range>
            <pub-id pub-id-type="pmid">11952686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krolewiecki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nutman</surname>
                <given-names>TB</given-names>
              </name>
            </person-group>
            <article-title>Strongyloidiasis: A Neglected Tropical Disease.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>135</fpage>
            <page-range>135-151</page-range>
            <pub-id pub-id-type="pmid">30712758</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lodh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Caro</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sofer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Krolewiecki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shiff</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of Strongyloides stercoralis: Detection of parasite-derived DNA in urine.</article-title>
            <source>Acta Trop</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>163</volume>
            <fpage>9</fpage>
            <page-range>9-13</page-range>
            <pub-id pub-id-type="pmid">27456935</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arifin</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hanafiah</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Noordin</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Serodiagnosis and early detection of Strongyloides stercoralis infection.</article-title>
            <source>J Microbiol Immunol Infect</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>52</volume>
            <issue>3</issue>
            <fpage>371</fpage>
            <page-range>371-378</page-range>
            <pub-id pub-id-type="pmid">30482708</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Campo Polanco</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Guti&#x000e9;rrez</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Cardona Arias</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>[Diagnosis of Strongyloides Stercoralis infection: meta-analysis on evaluation of conventional parasitological methods (1980-2013)].</article-title>
            <source>Rev Esp Salud Publica</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>88</volume>
            <issue>5</issue>
            <fpage>581</fpage>
            <page-range>581-600</page-range>
            <pub-id pub-id-type="pmid">25327268</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levenhagen</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Costa-Cruz</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Update on immunologic and molecular diagnosis of human strongyloidiasis.</article-title>
            <source>Acta Trop</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>135</volume>
            <fpage>33</fpage>
            <page-range>33-43</page-range>
            <pub-id pub-id-type="pmid">24686097</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buonfrate</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Formenti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Perandin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bisoffi</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Novel approaches to the diagnosis of Strongyloides stercoralis infection.</article-title>
            <source>Clin Microbiol Infect</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>21</volume>
            <issue>6</issue>
            <fpage>543</fpage>
            <page-range>543-52</page-range>
            <pub-id pub-id-type="pmid">25887711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitchell</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Weinberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Phares</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>James</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Amornpaisarnloet</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Aumpipat</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cooley</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tin Shwe</surname>
                <given-names>VD</given-names>
              </name>
              <name>
                <surname>Gajdadziev</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gorbacheva</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Khwan-Niam</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Klosovsky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Madilokkowit</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Htun Myint</surname>
                <given-names>NZ</given-names>
              </name>
              <name>
                <surname>Yen Nguyen</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Nutman</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>O'Connell</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Ortega</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Prayadsab</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Srimanee</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Supakunatom</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Vesessmith</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Stauffer</surname>
                <given-names>WM</given-names>
              </name>
            </person-group>
            <article-title>Impact of Enhanced Health Interventions for United States-Bound Refugees: Evaluating Best Practices in Migration Health.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>98</volume>
            <issue>3</issue>
            <fpage>920</fpage>
            <page-range>920-928</page-range>
            <pub-id pub-id-type="pmid">29260657</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Geri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rabbat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mayaux</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zafrani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chalumeau-Lemoine</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Guidet</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Azoulay</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>P&#x000e8;ne</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Strongyloides stercoralis hyperinfection syndrome: a case series and a review of the literature.</article-title>
            <source>Infection</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>43</volume>
            <issue>6</issue>
            <fpage>691</fpage>
            <page-range>691-8</page-range>
            <pub-id pub-id-type="pmid">26008854</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ming</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chiodini</surname>
                <given-names>PL</given-names>
              </name>
              <name>
                <surname>Doherty</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Whitty</surname>
                <given-names>CJM</given-names>
              </name>
              <name>
                <surname>McGregor</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Clinical and Diagnostic Features of 413 Patients Treated for Imported Strongyloidiasis at the Hospital for Tropical Diseases, London.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>101</volume>
            <issue>2</issue>
            <fpage>428</fpage>
            <page-range>428-431</page-range>
            <pub-id pub-id-type="pmid">31219002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Segarra-Newnham</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.</article-title>
            <source>Ann Pharmacother</source>
            <year>2007</year>
            <month>Dec</month>
            <volume>41</volume>
            <issue>12</issue>
            <fpage>1992</fpage>
            <page-range>1992-2001</page-range>
            <pub-id pub-id-type="pmid">17940124</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Luvira</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Watthanakulpanich</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pittisuttithum</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Management of Strongyloides stercoralis: a puzzling parasite.</article-title>
            <source>Int Health</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>273</fpage>
            <page-range>273-81</page-range>
            <pub-id pub-id-type="pmid">25173343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Henriquez-Camacho</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gotuzzo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Echevarria</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Terashima</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Samalvides</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Molina</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Plana</surname>
                <given-names>MN</given-names>
              </name>
            </person-group>
            <article-title>Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2016</year>
            <month>Jan</month>
            <day>18</day>
            <volume>2016</volume>
            <issue>1</issue>
            <fpage>CD007745</fpage>
            <pub-id pub-id-type="pmid">26778150</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lam</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Siu</surname>
                <given-names>YP</given-names>
              </name>
            </person-group>
            <article-title>Disseminated strongyloidiasis: a retrospective study of clinical course and outcome.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-8</page-range>
            <pub-id pub-id-type="pmid">16418832</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>El Masry</surname>
                <given-names>HZ</given-names>
              </name>
              <name>
                <surname>O'Donnell</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Fatal stongyloides hyperinfection in heart transplantation.</article-title>
            <source>J Heart Lung Transplant</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>24</volume>
            <issue>11</issue>
            <fpage>1980</fpage>
            <page-range>1980-3</page-range>
            <pub-id pub-id-type="pmid">16297809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Requena-M&#x000e9;ndez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Buonfrate</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gomez-Junyent</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zammarchi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bisoffi</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Evidence-Based Guidelines for Screening and Management of Strongyloidiasis in Non-Endemic Countries.</article-title>
            <source>Am J Trop Med Hyg</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>97</volume>
            <issue>3</issue>
            <fpage>645</fpage>
            <page-range>645-652</page-range>
            <pub-id pub-id-type="pmid">28749768</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29576.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strunz</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Addiss</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Stocks</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Ogden</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Utzinger</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Freeman</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>Water, sanitation, hygiene, and soil-transmitted helminth infection: a systematic review and meta-analysis.</article-title>
            <source>PLoS Med</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>e1001620</fpage>
            <pub-id pub-id-type="pmid">24667810</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
